Long-term Study to Evaluate Safety and Persistence of GF-CART01 (NCT06985576) | Clinical Trial Compass
By InvitationNot Applicable
Long-term Study to Evaluate Safety and Persistence of GF-CART01
Taiwan18 participantsStarted 2026-02-26
Plain-language summary
The goal of this observational study is to learn about the long-term safety of GF-CART01 after cell infusion up to 15 years.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Subjects previously enrolled in the study of GF-CART01 (Protocol No.: GF-01-01) and received GF-CART01 infusion
. Subjects or their legal guardians must volunteer to participate in the study and sign the informed consent
. Willingness and ability to comply with protocol-stated requirements, instructions, and restrictions in the investigator's judgement
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this is a long-term safety follow-up study for people who already received GF-CART01, does my treatment history make me someone who might be invited to join, and how would that invitation process work?
2What specific long-term risks or late-appearing side effects is this study designed to watch for after a CAR-T cell therapy like GF-CART01, and how does that compare to what's already known about other CAR-T treatments for DLBCL or follicular lymphoma?
3How long would I need to participate in this follow-up study, and what does ongoing monitoring actually involve in terms of clinic visits, tests, or lifestyle considerations?
4Since this study is listed as 'Phase NA' and focuses on safety follow-up rather than testing a new treatment, what does that mean for what we might learn from it, and how does it affect my care going forward?
5If I or a family member were eligible for this study, would participating change or limit any other treatment options I might be considering for my lymphoma?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Long-Term Safety of GF-CART01 after infusion
Timeframe: up to 15 years after GF-CART01 infusion